 |
|
|
| |
Pharmacokinetics of Cyclosporine and Tacrolimus, Following Coadministration with the Direct Acting Antiviral Combination, ABT-450/r,
Ombitasvir and Dasabuvir, in Liver Transplant Patients with Genotype-1 HCV Infection
|
| |
| |
Reported by Jules Levin
AASLD 2014 Nov 7-11 Boston
Prajakta Badri, Apurvasena Parikh, Eoin Coakley, Bifeng Ding, Walid Awni, Sandeep Dutta, Rajeev Menon
AbbVie Inc., North Chica
AASLD: HIGH SUSTAINED VIROLOGIC RESPONSE RATES IN LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HCV GENOTYPE 1 INFECTION RECEIVING ABT-450/r/OMBITASVIR + DASABUVIR PLUS RIBAVIRIN CORAL-1 Study - (11/12/14)
|
| |
|
|
|
|
|
